| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6946120 | JOHNSON AND JOHNSON | Pharmaceutical composition |
Apr, 2019
(5 years ago) | |
Women'S Rogaine is owned by Johnson And Johnson.
Women'S Rogaine contains Minoxidil.
Women'S Rogaine has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Women'S Rogaine are:
- US6946120
Women'S Rogaine was authorised for market use on 20 January, 2006.
Women'S Rogaine is available in aerosol, foam;topical dosage forms.
Women'S Rogaine can be used as topical aerosol hair regrowth treatment.
The generics of Women'S Rogaine are possible to be released after 20 April, 2019.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Feb 28, 2017 |
Drugs and Companies using MINOXIDIL ingredient
Market Authorisation Date: 20 January, 2006
Treatment: Topical aerosol hair regrowth treatment
Dosage: AEROSOL, FOAM;TOPICAL
How can I launch a generic of WOMEN'S ROGAINE before it's drug patent expiration?
More Information on Dosage
WOMEN'S ROGAINE family patents
